These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

787 related items for PubMed ID: 11694805

  • 1. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M, Centanni S, Boveri B, Di Marco F, Santus P, Matera MG, Allegra L.
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [Abstract] [Full Text] [Related]

  • 2. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS, Nathan RA, Kalberg C, Yancey SW, Rickard KA.
    MedGenMed; 2001 Jul 05; 3(4):3. PubMed ID: 11549982
    [Abstract] [Full Text] [Related]

  • 3. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ, Winter TH, Aalbers R.
    Thorax; 2001 Jul 05; 56(7):529-35. PubMed ID: 11413351
    [Abstract] [Full Text] [Related]

  • 4. Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.
    Cazzola M, Di Perna F, Noschese P, Vinciguerra A, Calderaro F, Girbino G, Matera MG.
    Eur Respir J; 1998 Jun 05; 11(6):1337-41. PubMed ID: 9657576
    [Abstract] [Full Text] [Related]

  • 5. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
    Busse W, Nelson H, Wolfe J, Kalberg C, Yancey SW, Rickard KA.
    J Allergy Clin Immunol; 1999 Jun 05; 103(6):1075-80. PubMed ID: 10359889
    [Abstract] [Full Text] [Related]

  • 6. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B, Markham A.
    Drugs Aging; 2001 Jun 05; 18(6):441-72. PubMed ID: 11419918
    [Abstract] [Full Text] [Related]

  • 7. Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist.
    Cazzola M, Boveri B, Carlucci P, Santus P, DiMarco F, Centanni S, Allegra L.
    Pulm Pharmacol Ther; 2000 Jun 05; 13(6):301-5. PubMed ID: 11061985
    [Abstract] [Full Text] [Related]

  • 8. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C, Testi R, Polese G, Tosatto R, Rossi A.
    Pulm Pharmacol Ther; 2005 Jun 05; 18(2):103-8. PubMed ID: 15649852
    [Abstract] [Full Text] [Related]

  • 9. Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD.
    Cazzola M, Santus P, Di Marco F, Boveri B, Castagna F, Carlucci P, Matera MG, Centanni S.
    Respir Med; 2003 May 05; 97(5):453-7. PubMed ID: 12735659
    [Abstract] [Full Text] [Related]

  • 10. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP.
    Clin Ther; 2007 Feb 05; 29(2):261-78. PubMed ID: 17472819
    [Abstract] [Full Text] [Related]

  • 11. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S, Swystun VA, Bhagat R, Cockcroft DW.
    Chest; 1996 Apr 05; 109(4):953-6. PubMed ID: 8635376
    [Abstract] [Full Text] [Related]

  • 12. Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
    Cazzola M, Calderaro F, Califano C, Di Pema F, Vinciguerra A, Donner CF, Matera MG.
    Eur J Clin Pharmacol; 1999 Jan 05; 54(11):829-33. PubMed ID: 10027655
    [Abstract] [Full Text] [Related]

  • 13. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
    Bateman ED, van Dyk M, Sagriotis A.
    Pulm Pharmacol Ther; 2008 Jan 05; 21(1):20-5. PubMed ID: 17118684
    [Abstract] [Full Text] [Related]

  • 14. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI.
    JAMA; 1994 May 11; 271(18):1412-6. PubMed ID: 7909853
    [Abstract] [Full Text] [Related]

  • 15. Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease.
    Cazzola M, Vinciguerra A, Di Perna F, Matera MG.
    Respir Med; 1998 Aug 11; 92(8):1012-6. PubMed ID: 9893768
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
    Ulrik CS.
    Thorax; 1995 Jul 11; 50(7):750-4. PubMed ID: 7570409
    [Abstract] [Full Text] [Related]

  • 17. Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype.
    Lipworth BJ, Dempsey OJ, Aziz I, Wilson AM.
    Am J Med; 2000 Aug 01; 109(2):114-21. PubMed ID: 10967152
    [Abstract] [Full Text] [Related]

  • 18. Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD.
    Cazzola M, Califano C, Di Perna F, D'Amato M, Terzano C, Matera MG, D'Amato G, Marsico SA.
    Respir Med; 2002 Oct 01; 96(10):790-5. PubMed ID: 12412978
    [Abstract] [Full Text] [Related]

  • 19. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 01; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 20. Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.
    Dunn CJ, Goa KL.
    Drugs; 2001 Mar 01; 61(2):285-315. PubMed ID: 11270943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.